Navigation Links
Two-Time Super Bowl Champion Coach & Sports Broadcaster Jimmy Johnson Laughs About His 'Notoriety' in New ExtenZe Spots from Inter/Media Advertising
Date:10/6/2010

roduct scored number one in sales in the Mineral Supplement category at retailers for the past 104 weeks, according to InfoScan Reviews.

The new ExtenZe spots will air on ESPN, BET, Discovery, AMC, FX and Speed Networks, among others. The campaign spots have been produced and directed by Oscar Bassinson, Creative Director of Inter/Media Advertising and President of Inter/media subsidiary Inter/Image Productions.

Inter/Media Advertising has gained a national reputation for uniquely blending direct response advertising with general market techniques. Inter/Media does breakthrough, award-winning advertising and media for such companies as the US Army, Johnson and Johnson, Neutrogena, Ubisoft, Budget Blinds, Fly.com, Biotab Nutraceuticals, Marinello Schools of Beauty, Video Professor and Corinthian Colleges, among others.

For more information on Inter/Media Advertising, contact Yallen at ryallen@intermedia-advertising.com or 1 (800) Time-Buy.

About ExtenZe

ExtenZe is the best selling male enhancement product sold worldwide. It is a proprietary blend of pharmaceutical grade substances to make a revolutionary product for men. Laboratory tested and with no harmful side effects, ExtenZe is the most advanced product of its kind and it can work for men of any age. With more than a billion tablets sold, ExtenZe is now available at Wal-Mart, Walgreens, CVS, Rite Aid, GNC and most major stores. For more information go to www.extenze.com

About Inter/Media Group of Companies

Inter/Media Advertising is a fully integrated $450-million advertising agency and media organization that uniquely blends direct response advertising with general market techniques.  Founded in 1974 and recognized as a major force in the direct response advertising industry, Inter/Media also specializes in retail brand building and advertising
'/>"/>

SOURCE Inter/Media Advertising
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients
2. New York Plastic Surgery News: Medical Tourists Beware of Drug-Resistant Superbug NDM-1
3. BCM-95 Demonstrates Superior Anti-Inflammatory Effects
4. New Super Exam 50® LED from Burton Medical Provides the Most Positionable, High Intensity Diagnostic Light Available
5. Burton Medical Offers Affordable and Superior Illumination With New LE-35
6. Sacramento County Board of Supervisors Declare Voices of Meningitis Week
7. New Supercomputer Connection Speeds Genetic Research
8. Newly Published Data Demonstrate ASP EVOTECH® ECR Provides Cleaning That is Superior to Manual Cleaning of Flexible Endoscopes
9. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year
10. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at 52 Weeks
11. The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014   Royal Philips ... today announced it has received 510(k) clearance from ... its precision planning application for Transcatheter Aortic-Valve Implantation ... application provides interventionalists with pre-procedural, high-precision positioning to ... TAVI planning application is available as part of ...
(Date:8/21/2014)... 2014   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... today announced positive results from a randomized, double-blind ... CCH) for the treatment of edematous fibrosclerotic panniculopathy ... 2a trial, all three doses of CCH (low ... improvement in the appearance of cellulite as measured ...
(Date:8/20/2014)... The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 7,481 boxes of ...
Breaking Medicine Technology:Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 2011 Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ... receiving concomitant systemic antibiotics in two Phase 3 clinical ... the treatment of adult patients with Clostridium difficile ... 1 issue of Clinical Infectious Diseases (CID). ...
... Aug. 16, 2011 Marshall Edwards, Inc. (Nasdaq: ... clinical development of novel therapeutics targeting cancer metabolism, announced ... ME-143 (formerly NV-143), the Company,s lead NADH oxidase inhibitor, ... Administration (FDA). The Company plans to initiate a Phase ...
Cached Medicine Technology:Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 2Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 3Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 4Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 5Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 6Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143 2Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143 3
(Date:8/22/2014)... 22, 2014 Dealing with a drug or ... the addict is a child. Adolescent substance abuse has been ... long time. But a new helpline is now providing a ... youth rehab for something like a teen drug addiction ... to help make a positive impact in the community. By ...
(Date:8/22/2014)... According to the market research report "Blind ... (ACC) System Market for Passenger Cars; by Geography ... by MarketsandMarkets, classifies and defines the automotive BSD ... and value. The report highlights potential growth opportunities ... review of the market drivers, restrains, growth indicators, ...
(Date:8/21/2014)... Petersburg, FL (PRWEB) August 22, 2014 The ... behind those fine lines, wrinkles and sagging of skin. ... loss. , "By age 40, the body has lost about ... has lost about 45%," says Kathy Heshelow, founder of Sublime ... with less of it - well, we know what happens." ...
(Date:8/21/2014)... York, NY (PRWEB) August 21, 2014 ... can often have larger discounts for specific protection plans, ... is now helping consumers to quote life insurance from ... , The local agents that appear inside of ... offer a fast method of price reviews this year. ...
(Date:8/21/2014)... 21, 2014 AVEC Health Solutions, ... the addition of Kerry Gillespie as Chief Executive ... management experience, Gillespie brings an extremely robust background ... management positions with prominent industry leading organizations across ... President of Triad Isotopes, Inc. a private nuclear ...
Breaking Medicine News(10 mins):Health News:Cincinnati’s New Troubled Teen Helpline is Making a Difference in the Community 2Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 2Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 3Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 4Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 2Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 3Health News:Life Insurance from Local Agents Now Priced Nationally Through Complimentary Tool Online 2Health News:Kerry Gillespie Appointed as Chief Executive Officer of AVEC Health Solutions 2
... was issued,today by the law firm of Schiffrin Barroway Topaz ... class action lawsuit was filed in the,United States District Court ... of securities of Healthways Inc. (Nasdaq: HWAY ),("Healthways" or ... (the "Class Period")., If you wish to discuss this ...
... The University of Illinois at Chicago is one of ... Norway to participate in the Clinical Islet Transplant Consortium ... researchers have begun clinical studies to test new approaches ... and fewer side effects for adults with difficult-to-control type ...
... U.S. Senate to vote soon on legislation that ... New Hampshire, WASHINGTON, July 8 Seniors ... to the Medicare Advantage,program in legislation being considered ... cut $6.6 million from the Medicare Advantage program ...
... Pittsburgh-led researchers could provide new insight into how ... arteriovenous malformations (AVMs)develop in humans, as reported in ... . , Led by Beth Roman, an assistant ... Arts and Sciences, the team created the first ...
... rates no different than ,watchful waiting, study shows , , ... therapy used for localized prostate cancer may not bestow ... with a simple "wait-and-see" approach. , Men taking androgen ... promote tumor growth, even had a slightly lower ...
... From the Committee to Reduce Infection Deaths (RID), ... to be,proud of," says Betsy McCaughey, Chairman of the ... of New York State. The New York,State Hospital-Acquired Infection ... performance with national infection,rate averages, and finds the state ...
Cached Medicine News:Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 2Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 3Health News:UIC in NIH-funded islet transplantation study for type 1 diabetes 2Health News:New Hampshire Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Pitt-led research provides insight into development of congenital circulatory defects 2Health News:Hormone Therapy Shows Little Benefit Against Prostate Cancer 2Health News:Hormone Therapy Shows Little Benefit Against Prostate Cancer 3Health News:It's the Same Old Song: 'Accentuate the Positive' as New York State Department of Health Releases Statewide Hospital Infection Rates 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: